Cargando…
2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710261/ https://www.ncbi.nlm.nih.gov/pubmed/36457968 http://dx.doi.org/10.5114/aoms/156147 |
| _version_ | 1784841327083520000 |
|---|---|
| author | Banach, Maciej Reiner, Zeljko Cicero, Arrigo F.G. Sabouret, Pierre Viigimaa, Margus Sahebkar, Amirhossein Postadzhiyan, Arman Gaita, Dan Pella, Daniel Penson, Peter E. |
| author_facet | Banach, Maciej Reiner, Zeljko Cicero, Arrigo F.G. Sabouret, Pierre Viigimaa, Margus Sahebkar, Amirhossein Postadzhiyan, Arman Gaita, Dan Pella, Daniel Penson, Peter E. |
| author_sort | Banach, Maciej |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9710261 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97102612022-11-30 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy Banach, Maciej Reiner, Zeljko Cicero, Arrigo F.G. Sabouret, Pierre Viigimaa, Margus Sahebkar, Amirhossein Postadzhiyan, Arman Gaita, Dan Pella, Daniel Penson, Peter E. Arch Med Sci Invited Editorial Termedia Publishing House 2022-11-07 /pmc/articles/PMC9710261/ /pubmed/36457968 http://dx.doi.org/10.5114/aoms/156147 Text en Copyright: © 2022 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
| spellingShingle | Invited Editorial Banach, Maciej Reiner, Zeljko Cicero, Arrigo F.G. Sabouret, Pierre Viigimaa, Margus Sahebkar, Amirhossein Postadzhiyan, Arman Gaita, Dan Pella, Daniel Penson, Peter E. 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| title | 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| title_full | 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| title_fullStr | 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| title_full_unstemmed | 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| title_short | 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| title_sort | 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy |
| topic | Invited Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710261/ https://www.ncbi.nlm.nih.gov/pubmed/36457968 http://dx.doi.org/10.5114/aoms/156147 |
| work_keys_str_mv | AT banachmaciej 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT reinerzeljko 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT ciceroarrigofg 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT sabouretpierre 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT viigimaamargus 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT sahebkaramirhossein 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT postadzhiyanarman 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT gaitadan 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT pelladaniel 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy AT pensonpetere 2022theyearincardiovasculardiseasetheyearofupfrontlipidloweringcombinationtherapy |